View clinical trials related to Recurrent Lymphoma, Mantle-Cell.
Filter by:The purpose of this study is to determine the optimal dosing scheme for the combination of ibrutinib with ABT-199 for the treatment of relapsed or refractory mantle cell lymphoma (MCL).